Announcements Trials
Browse Landscape

Status

Terminated 2Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 26Observational 5

Sponsor

Cancer Type

Thoracic 5

Conditions

Breast Neoplasms 2929Neoplasms 2624Lung Neoplasms 1366Colorectal Neoplasms 1328Prostatic Neoplasms 1214Carcinoma, Non-Small-Cell Lung 1079Carcinoma, Hepatocellular 782Stomach Neoplasms 720Pancreatic Neoplasms 701Ovarian Neoplasms 586Colonic Neoplasms 533Uterine Cervical Neoplasms 497Head and Neck Neoplasms 495Rectal Neoplasms 472Melanoma 467Multiple Myeloma 463Esophageal Neoplasms 422Neoplasm Metastasis 418Brain Neoplasms 404Lymphoma 399Precursor Cell Lymphoblastic Leukemia-Lymphoma 397Urinary Bladder Neoplasms 386Leukemia, Myeloid, Acute 385Leukemia 339Carcinoma, Renal Cell 329Liver Neoplasms 320Endometrial Neoplasms 319Hematologic Neoplasms 312Recurrence 298Disease 272

Interventions

Data Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Observational × Non-small Cell Lung Cancer Metastatic × Clear all
NCT04994795 2024-11-21

DEEP-Lung-IV

Sophia Genetics SAS

Active not recruiting
4,000 enrolled
Thoracic

Non-small Cell Lung Cancer Metastatic

NCT01523340 2021-08-03

MENTOR

Chonnam National University Hospital

Completed
196 enrolled
Thoracic

Non-small Cell Lung Cancer Metastatic

NCT02228421 2020-03-11

Study to Evaluate Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients

PeriPharm

Terminated
29 enrolled
Thoracic

Non-small Cell Lung Cancer Metastatic

NCT03477474 2019-10-10

GEODE

Guardant Health, Inc.

Terminated
311 enrolled
Thoracic

Non-small Cell Lung Cancer Metastatic

NCT02041468 2017-08-30

Study to Evaluate Resistance Mechanisms and Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients

Jewish General Hospital

Unknown
29 enrolled
Thoracic

Non-small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡